CRESCENT BIOPHARMA, INC. Noncash or Part Noncash Acquisition, Payables Assumed
CRESCENT BIOPHARMA, INC. (CBIO) reported Noncash or Part Noncash Acquisition, Payables Assumed of $10.46 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1 · last filed 2015-08-06
- CRESCENT BIOPHARMA, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2015-06-30 was $464.00.
- CRESCENT BIOPHARMA, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2015-03-31 was $10.00K.
| Period end | Noncash or Part Noncash Acquisition, Payables Assumed 3 month | Noncash or Part Noncash Acquisition, Payables Assumed 6 month |
|---|---|---|
| 2015-06-30 | $464.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $10.46K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $10.00K 10-Q · filed 2015-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |